Latest filing published 01 Sept 2025 for 바스칸바이오제약.
민천기: trading record in brief
민천기 discloses dealings in 바스칸바이오제약 to DART (FSS). Over a trading history stretching from 25 July 2022 to 1 September 2025, the count stands at 11 filings.
The open-market record is one-sided, with 11 purchases and not one sale. The totals exclude 11 filings filed without an amount. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Since January 2025: 1 purchase and no sales on the market.
No cluster: in 10 purchases, no other insider of the company bought within 30 days.
The newest entry dates from 1 September 2025: an open-market purchase, in 바스칸바이오제약. Source: insider filings from DART (FSS). Past trades are no guide to future returns.
Companies and markets linked to 민천기
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- ShareKRXDART:20230725000427Canonical exit: 23 Oct 2023 (T+90)
- ShareKRXDART:20230725000202Canonical exit: 23 Oct 2023 (T+90)
- ShareKRXDART:20220727000014Canonical exit: 25 Oct 2022 (T+90)
- ShareKRXDART:20220726000040Canonical exit: 24 Oct 2022 (T+90)
- ShareKRXDART:20220726000054Canonical exit: 24 Oct 2022 (T+90)
- ShareKRXDART:20220725000298Canonical exit: 23 Oct 2022 (T+90)
- ShareKRXDART:20220725000108Canonical exit: 23 Oct 2022 (T+90)
- ShareKRXDART:20220725000185Canonical exit: 23 Oct 2022 (T+90)
- ShareKRXDART:20220725000113Canonical exit: 23 Oct 2022 (T+90)
- ShareKRXDART:20220725000070Canonical exit: 23 Oct 2022 (T+90)
11 of 11 declarations